Eisai
4523.T
#1880
Rank
NZ$15.03 B
Marketcap
$53.34
Share price
0.82%
Change (1 day)
-35.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.71. In 2022 the company made an earnings per share (EPS) of $2.72 a decrease over its 2021 EPS that were of $12.09.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5429.98%
2022$2.72-77.48%
2021$12.09-41.88%
2020$20.80-0.94%
2019$21.0052.59%
2018$13.76124.17%
2017$6.14-49.42%
2016$12.1437.08%
2015$8.86-11.75%
2014$10.03-3.23%
2013$10.37-18.56%
2012$12.73-15.51%
2011$15.07-3.75%
2010$15.66-1.36%
2009$15.88